<DOC>
	<DOCNO>NCT01261273</DOCNO>
	<brief_summary>Title Prospective , single-arm , multi-centre , observational registry validate safety efficacy Nobori® DES real-world patient . Objective Primary objective The primary objective e-NOBORI registry validate safety efficacy Nobori® DES system unselected patient represent everyday clinical practice . Primary Endpoint : Freedom Target Lesion Failure ( TLF ) define composite cardiac death , target vessel related myocardial infarction ( MI ) clinically drive target lesion revascularization ( TLR ) 1 year</brief_summary>
	<brief_title>e-NOBORI Observational Registry Nobori DES</brief_title>
	<detailed_description>- Title Prospective , single-arm , multi-centre , observational registry validate safety efficacy Nobori® DES real-world patient . - Primary objective The primary objective e-NOBORI registry validate safety efficacy Nobori® DES system unselected patient represent everyday clinical practice . - Primary Endpoint : Freedom Target Lesion Failure ( TLF ) define composite cardiac death , target vessel related myocardial infarction ( MI ) clinically drive target lesion revascularization ( TLR ) 1 year - Clinical Site Locations : Up 200 centre across Europe , Asia Central South America -Patient Population : ~18000 eligible patient suitable treatment Nobori® DES enter e-NOBORI registry Eligibility Criteria - Patient equal 18 year old ; - Patient , accord hospital routine practice , eligible percutaneous coronary intervention use DES ( RVD match available Nobori® DES size ) ; - Patient informed nature study agree provision , provide write informed consent approve Institutional Review Board/Ethics Committee respective clinical site , wherever requirement exists . NOTE : In order avoid bias recommend investigator aim enrol consecutive patient comply study eligibility criterion . It also desirable least two cardiologist investigator centre . According pre-specified criterion , patient automatically allocate one sub-studies follow : - NOBORI Acute Coronary Syndrome - NOBORI Stable angina - NOBORI Female - NOBORI Bifurcation - NOBORI Diabetes - Insulin Dependent Diabetes Mellitus ( IDDM ) - Non-Insulin Dependent Diabetes Mellitus ( NIDDM ) - NOBORI Small Vessels ( less equal 2.75mm ) - NOBORI Long Lesions ( equal 20mm ) - NOBORI Renal Insufficiency ( &gt; 2.0 mg/dL - 176 µmol/mL ) - NOBORI Elderly ( equal 80 year age ) - NOBORI Restenosis - NOBORI Multivessel Treatment - NOBORI Complex Lesions In addition mention sub-studies geographic sub-studies main area . Medication Pre-Procedure : According hospital routine practice Post-Procedure : Mandatory antiplatelet treatment , accord hospital routine practice ( minimum 6 month DAT )</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Patient equal 18 year old ; Patient , accord hospital routine practice , eligible percutaneous coronary intervention use DES ( RVD match available Nobori® DES size ) ; Patient inform nature study agree provision , provide write informed consent approve Institutional Review Board/Ethics Committee respective clinical site , wherever requirement exists .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>PCI</keyword>
	<keyword>observational registry</keyword>
</DOC>